Emergency Medicine
Episodes 1-16 of 25
Manesh R. Patel, MD
Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC
Manesh R. Patel, MD
Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC
Manesh R. Patel, MD
Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC
Manesh R. Patel, MD
Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC
Manesh R. Patel, MD
W. Brian Gibler, MD, FACEP, FACC, FAHA
Natalie Kreitzer, MD, MS
Adrian R. Parry-Jones, FRCP, PhD
Hiren C. Patel, PhD, FRCS
David Seiffge, MD
Thorsten Steiner, MD, PhD, MME
W. Brian Gibler, MD, FACEP, FACC, FAHA
Natalie Kreitzer, MD, MS
Adrian R. Parry-Jones, FRCP, PhD
Hiren C. Patel, PhD, FRCS
David Seiffge, MD
Thorsten Steiner, MD, PhD, MME
- MinuteCE®
Optimizing Your Pharmacologic Approach to Reversing Anticoagulation for ICH
1.50 program creditsDavid Seiffge, MD
Natalie Kreitzer, MD, MS
W. Brian Gibler, MD, FACEP, FACC, FAHA
- MinuteCE®
Does Care Bundling Improve Outcomes for Patients with Intracranial Hemorrhage?
1.50 program creditsAdrian R. Parry-Jones, FRCP, PhD
W. Brian Gibler, MD, FACEP, FACC, FAHA
Hiren C. Patel, PhD, FRCS
David Seiffge, MD
Natalie Kreitzer, MD, MS
W. Brian Gibler, MD, FACEP, FACC, FAHA
Thorsten Steiner, MD, PhD, MME
Adrian R. Parry-Jones, FRCP, PhD
Hiren C. Patel, PhD, FRCS
W. Brian Gibler, MD, FACEP, FACC, FAHA
Adrian R. Parry-Jones, FRCP, PhD
Thorsten Steiner, MD, PhD, MME
- MinuteCE®
ESO Guidelines for the Management of ICH in the Anticoagulated Patient
1.50 program creditsThorsten Steiner, MD, PhD, MME
W. Brian Gibler, MD, FACEP, FACC, FAHA
David Seiffge, MD
Adrian R. Parry-Jones, FRCP, PhD
Natalie Kreitzer, MD, MS
- MinuteCE®
VTE Prophylaxis in Patients at Risk for a Secondary VTE Event - Options?
1.75 program creditsScott Kaatz, DO, MSc, FACP, SFHM
Deborah Siegal, MD, MSc, FRCPC
- MinuteCE®
What Do the Guidelines Suggest for Prophylaxis, and How Do We Implement?
1.75 program creditsAlfonso J. Tafur, MD, MS, MBA, RPVI
Alex C. Spyropoulos, MD, FACP, FCCP, FRCPC
Alfonso J. Tafur, MD, MS, MBA, RPVI
- Prev
- Next